Uracil C-13 is under investigation in clinical trial NCT01677338 (Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.